Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common chronic childhood disorders, and its prevalence is on the rise. National survey data from 2016 indicate that 9.4 percent of children in the United States ages 2 to 17 have had an ADHD diagnosis, including 2.4 percent of children 2 to 5 years of age. In that national survey, 8.4 percent of children ages 2 to 17 currently had ADHD, representing 5.4 million children. Among children and adolescents with current ADHD, almost two-thirds were taking medication, and approximately half had received behavioral treatment for ADHD in the past year. Nearly one quarter had received neither type of treatment of ADHD.

Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood. Children with ADHD may have difficulty controlling their behavior in school and social settings and often fail to achieve their full academic potential. Additionally, ADHD is frequently present with other psychiatric disorders.

La clé d'une prise en charge efficace à long terme de l'enfant atteint de TDAH est la continuité des soins avec des cliniciens expérimentés dans le traitement du TDAH. La fréquence et la durée des séances de suivi doivent être individualisées pour chaque famille et chaque enfant, en fonction de la gravité des symptômes du TDAH; le degré de comorbidité d'autres maladies psychiatriques; la réponse au traitement; et le degré de déficience à la maison, à l'école, au travail ou dans les activités liées aux pairs.

Lignes directrices pour le diagnostic et le traitement

Healthcare Effectiveness Data and Information Set (HEDIS®)1 Tip Sheets

Matériel pour les membres

Outils de dépistage

1 HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA).